Discordance in the Evaluation of Suicidal Intent Between Parents and Adolescents in Adolescence and Evolution of the Suicidal Crisis : a Mixed Study
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Sep 12, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how parents and their teenage children understand and assess the teen's feelings of wanting to harm themselves, especially after a suicide attempt. The researchers want to find out if differences in how parents and teens view the situation can affect the teen's recovery over three months. They will gather information by asking both the teens and their parents to fill out questionnaires at the start of the study and again after three months.
To participate, adolescents aged 11 to 17 who have recently been treated in a hospital after a suicide attempt and are fluent in spoken French are eligible, as long as they have at least one parent willing to join the study. Parents must be 18 or older and also fluent in spoken French. Participants can expect to share their experiences and feelings about the situation, which will help researchers better understand how to support families during these challenging times.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Adolescents:
- • aged 11 to 17
- • admitted to a pediatric or adult emergency department following a suicide attempt
- • proficient in spoken French
- • not opposed to participation in the research
- • accompanied by at least one parent who is not opposed to the adolescent's participation in the research.
- * Parents:
- • 18 years of age or older
- • parent or guardian of an adolescent admitted to a pediatric or adult emergency department following a suicide attempt
- • fluent in spoken French
- • not opposed to participation in the research
- Exclusion Criteria:
- • present a decompensated somatic or psychiatric pathology or a vigilance disorder
- • refusal to participate in the research
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported